HMGCR and triple-A syndrome: Another study found that in combination with the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, atorvastatin and amlodipine could reduce MMP-2 activity in an angiotensin II infusion animal model of AAA [151].